Small-molecule agents for cancer immunotherapy
Article in Acta Pharmaceutica Sinica B (December 2023)
The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.
Exploring the role of PI3K/AKT/mTOR inhibitors in hormone-related cancers: A focus on breast and prostate cancer
Article in Biomedicine & Pharmacotherapy (October 2023)
Metabolic and toxicological considerations for phosphoinositide 3-kinase delta inhibitors in the treatment of chronic lymphocytic leukemia
Article in Expert Opinion on Drug Metabolism & Toxicology (September 2023)